Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients. Issue 4 (15th March 2021)
- Record Type:
- Journal Article
- Title:
- Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients. Issue 4 (15th March 2021)
- Main Title:
- Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
- Authors:
- Colman, Ruben J
Portocarrero-Castillo, Andrea
Chona, Deepika
Hellmann, Jennifer
Minar, Phillip
Rosen, Michael J - Abstract:
- Is Part Of:
- Inflammatory bowel diseases. Volume 27:Issue 4(2021)
- Journal:
- Inflammatory bowel diseases
- Issue:
- Volume 27:Issue 4(2021)
- Issue Display:
- Volume 27, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 27
- Issue:
- 4
- Issue Sort Value:
- 2021-0027-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-03-15
- Subjects:
- anti-TNF immunogenicity -- pediatric infliximab -- pediatric adalimumab -- anti-TNF anti-drug antibodies -- anti-drug antibody reversal -- electrochemiluminescence-based immunoassay
Inflammatory bowel diseases -- Periodicals
Colitis, Ulcerative -- Periodicals
Crohn Disease -- Periodicals
Inflammatory Bowel Diseases -- Periodicals
616.344 - Journal URLs:
- http://journals.lww.com/ibdjournal/pages/default.aspx ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1536-4844/ ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=ovft&AN=00054725-000000000-00000 ↗
https://academic.oup.com/ibdjournal ↗
http://journals.lww.com ↗ - DOI:
- 10.1093/ibd/izaa108 ↗
- Languages:
- English
- ISSNs:
- 1078-0998
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4478.845400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18957.xml